Timing of Mortality After Severe Bleeding and Recurrent Myocardial Infarction in Patients With ST-Segment-Elevation Myocardial Infarction

被引:27
|
作者
Kikkert, Wouter J. [1 ]
Zwinderman, Aeilko H. [2 ]
Vis, Marije M. [1 ]
Baan, Jan, Jr. [1 ]
Koch, Karel T. [1 ]
Peters, Ron J. [1 ]
de Winter, Robbert J. [1 ]
Piek, Jan J. [1 ]
Tijssen, Jan G. P. [1 ]
Henriques, Jose P. S. [1 ]
机构
[1] Univ Amsterdam, Acad Med Ctr, Dept Cardiol, NL-1105 AZ Amsterdam, Netherlands
[2] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol Biostat & Bioinformat, NL-1105 AZ Amsterdam, Netherlands
关键词
major bleeding; primary percutaneous coronary intervention; recurrent myocardial infarction; ST-segment-elevation myocardial infarction; PERCUTANEOUS CORONARY INTERVENTION; ACUITY ACUTE CATHETERIZATION; AMI HARMONIZING OUTCOMES; PRIMARY ANGIOPLASTY; CLINICAL-OUTCOMES; BLOOD-TRANSFUSION; TRIAGE STRATEGY; CLOPIDOGREL; PREDICTORS; IMPACT;
D O I
10.1161/CIRCINTERVENTIONS.113.000425
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-The prognosis of initial survivors of ST-segment-elevation myocardial infarction (STEMI) is affected by both recurrent myocardial infarction (MI) and severe bleeding. The aim of the current study was to investigate how mortality is affected in time after bleeding and recurrent MI. Methods and Results-From January 1, 2003, to July 31, 2008, a total of 2002 patients were treated with primary percutaneous coronary intervention for ST-segment-elevation MI and followed up for the occurrence of recurrent MI and Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Arteries (GUSTO) severe bleeding. Primary outcome was all-cause mortality within 4 years of follow-up. In a time-dependent, covariate-adjusted Cox regression model, both bleeding and recurrent MI were associated with an increase in mortality shortly after the adverse event: hazard ratio, 14.37 (95% confidence interval [CI], 7.69-26.84) for the first day after recurrent MI and 5.42 (95% CI, 2.88-10.22) for the first day after bleeding. Thereafter the risk of subsequent mortality gradually decreased but remained elevated long after a recurrent MI (hazard ratio, 4.95 [95% CI, 3.27-7.48] between 1 day and 1 year after recurrent MI and hazard ratio, 2.56 [95% CI, 1.56-4.21] beyond 1 year after recurrent MI), but decreased to nonsignificant level beyond 1 month after the bleeding (hazard ratio, 0.56 [95% CI, 0.27-1.14]). Conclusions-The occurrence of both recurrent MI and bleeding in the first year after ST-segment-elevation MI is associated with subsequent mortality. The risk implication of recurrent MI, however, was greater and more sustained over time than that of severe bleeding.
引用
收藏
页码:391 / 398
页数:8
相关论文
共 50 条
  • [31] Non-high-density lipoprotein cholesterol predicts nonfatal recurrent myocardial infarction in patients with ST segment elevation myocardial infarction
    Ming Gao
    Yang Zheng
    Weihua Zhang
    Yi Cheng
    Lin Wang
    Ling Qin
    Lipids in Health and Disease, 16
  • [32] Admission Bedside Lung Ultrasound Reclassifies Mortality Prediction in Patients With ST-Segment-Elevation Myocardial Infarction
    Araujo, Gustavo N.
    Silveira, Anderson D.
    Scolari, Fernando L.
    Custodio, Julia L.
    Marques, Felipe P.
    Beltrame, Rafael
    Menegazzo, Wiliam
    Machado, Guilherme P.
    Fuchs, Felipe C.
    Goncalves, Sandro C.
    Wainstein, Rodrigo, V
    Leiria, Tiago L.
    Wainstein, Marco, V
    CIRCULATION-CARDIOVASCULAR IMAGING, 2020, 13 (06) : E010269
  • [33] ST-Segment-Elevation Myocardial Infarction Treatment and the Seductive Lure of Observational Analyses
    Munoz, Daniel
    Granger, Christopher B.
    CIRCULATION, 2011, 124 (23) : 2477 - 2479
  • [34] Comparison of Reperfusion Strategies for ST-Segment-Elevation Myocardial Infarction: A Multivariate Network Meta-analysis
    Fazel, Reza
    Joseph, Timothy, I
    Sankardas, Mullasari A.
    Pinto, Duane S.
    Yeh, Robert W.
    Kumbhani, Dharam J.
    Nallamothu, Brahmajee K.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2020, 9 (12):
  • [35] CRUSADE bleeding risk score validation for ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention
    Ariza-Sole, Albert
    Sanchez-Elvira, Guillermo
    Sanchez-Salado, Jose C.
    Lorente-Tordera, Victoria
    Salazar-Mendiguchia, Joel
    Sanchez-Prieto, Remedios
    Romaguera-Torres, Rafael
    Ferreiro-Gutierrez, Jose L.
    Gomez-Hospital, Joan A.
    Cequier-Fillat, Angel
    THROMBOSIS RESEARCH, 2013, 132 (06) : 652 - 658
  • [36] Pharmaco-Invasive Approach in Older Patients Presenting With ST-Segment-Elevation Myocardial Infarction
    Kastrati, Adnan
    Ndrepepa, Gjin
    CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2024, 17 (12)
  • [37] Exenatide Reduces Final Infarct Size in Patients With ST-Segment-Elevation Myocardial Infarction and Short-Duration of Ischemia
    Lonborg, Jacob
    Kelbaek, Henning
    Vejlstrup, Niels
    Botker, Hans Erik
    Kim, Won Yong
    Holmvang, Lene
    Jorgensen, Erik
    Helqvist, Steffen
    Saunamaki, Kari
    Terkelsen, Christian Juhl
    Schoos, Mikkel Malby
    Kober, Lars
    Clemmensen, Peter
    Treiman, Marek
    Engstrom, Thomas
    CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2012, 5 (02) : 288 - 295
  • [38] ST-Segment-Elevation Myocardial Infarction Care in America: Celebration and Anxiety
    Garratt, Kirk N.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2020, 9 (11):
  • [39] Bleeding risk in ST-segment elevation myocardial infarction
    Benamer, H.
    Meftout, B.
    Chevalier, B.
    ANNALES DE CARDIOLOGIE ET D ANGEIOLOGIE, 2010, 59 (06): : 356 - 361
  • [40] Evolution From Fibrinolytic Therapy to a Fibrinolytic Strategy for Patients With ST-Segment-Elevation Myocardial Infarction
    Bates, Eric R.
    CIRCULATION, 2014, 130 (14) : 1133 - 1135